CNS defects in a murine Zellweger syndrome model

小鼠齐薇格综合征模型中的中枢神经系统缺陷

基本信息

  • 批准号:
    7237179
  • 负责人:
  • 金额:
    $ 47.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-08 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our laboratory has been studying a murine PEX2 null animal model for the human peroxisomal biogenesis disorder Zellweger syndrome. We have determined that peroxisomal dysfunction in vivo affects neuronal proliferation, migration, survival and differentiation during CNS development. However, the contributions from intrinsic CNS defects versus extrinsic systemic organ dysfunctions and the role of peroxisomal lipid deficiencies or specific peroxisomal pathway defects have not been determined. We propose an integrated series of in vitro and in vivo approaches to address the following questions: Specific Aim #1. Are the defects in neuronal migration and differentiation in PEX2 -/- mice caused by factors intrinsic or extrinsic to the CNS? What is the role of peroxisomal lipid deficiencies or specific defects in peroxisomal B-oxidation or plasmalogen pathways in causing these abnormalities? We will directly visualize the dynamics of migrating neurons from control and PEX2 -/-mice by videomicroscopy using cerebral and cerebellar slice cultures and cerebellar neuron-glial cultures. The in vitro differentiation of control and PEX2 mutant cerebellar Purkinje cells and granule neurons will be examined. We will determine the effect of correcting deficiencies for plasmalogens or docosahexaenolc acid on the cellular defects in PEX2 neurons. We will compare the CNS defects observed in PEX2 -/- mice with those seen in mice with peroxisomal defects limited to plasmalogen and/or B-oxidation pathways (MFE2 -/-, MFE2/MFE1 -/-, PEX7 -/-) using these assays for neuronal migration and differentiation. We will evaluate the role of CNS intrinsic versus systemic peroxisomal dysfunction in the pathogenesis of CNS defects by both in vitro and in vivo transfection methods to restore PEX2 function in selected CNS cell types or brain regions. Alternatively, we will use in vivo transplantation of normal or peroxisome-defective neuronal progenitors into normal or mutant developing cerebral cortex or cerebellum. Specific Aim #2: Do hepatic factors contribute to the CNS defects in peroxisome defective mice? We will evaluate how CNS development is altered when bile acid deficiency is corrected in vivo in PEX2 -/-mice. We will determine whether bile acid products accumulate in the brain of PEX2 / mice. We will examine whether toxic substances from the PEX2 mutant liver cause CNS dysfunction by determining the effect of adding exogenous bile acid intermediates or hepatocyte conditioned medium on the in vitro neuronal defects in control, PEX2 -/, plasmalogen or B-oxidation defective mice. Specific Aim #3: What is the role for peroxisomes in developing cerebellar Purkinje cells and/or granule neurons? Conditional deletion of the PEX2 gene in cerebellar Purkinje cells and/or granule neurons will determine the role of peroxisomes for the development of these neurons in the absence of systemic organ peroxisome deficiency.
描述(由申请人提供):我们的实验室一直在研究人类过氧化物酶体生物发生障碍Zellweger综合征的鼠PEX 2无效动物模型。我们已经确定,体内过氧化物酶体功能障碍影响中枢神经系统发育过程中神经元的增殖,迁移,存活和分化。然而,内在的中枢神经系统缺陷与外在的全身器官功能障碍的贡献以及过氧化物酶体脂质缺乏或特定的过氧化物酶体途径缺陷的作用尚未确定。我们提出了一系列综合的体外和体内方法来解决以下问题:具体目标#1。PEX 2-/-小鼠神经元迁移和分化的缺陷是由中枢神经系统的内在因素还是外在因素引起的?过氧化物酶体脂质缺乏或过氧化物酶体B氧化或血浆酶原途径中的特定缺陷在导致这些异常中发挥什么作用?我们将通过使用大脑和小脑切片培养物和小脑神经元-胶质细胞培养物的视频显微镜直接观察来自对照和PEX 2-/-小鼠的迁移神经元的动态。将检查对照和PEX 2突变小脑浦肯野细胞和颗粒神经元的体外分化。我们将确定纠正缩醛磷脂或二十二碳六烯酸对PEX 2神经元细胞缺陷的影响。我们将使用这些神经元迁移和分化试验,比较在PEX 2-/-小鼠中观察到的CNS缺陷与在具有过氧化物酶体缺陷的小鼠中观察到的CNS缺陷,所述过氧化物酶体缺陷限于缩醛磷脂和/或B-氧化途径(MFE 2-/-、MFE 2/MFE 1-/-、PEX 7-/-)。我们将通过体外和体内转染方法评估CNS内在与全身过氧化物酶体功能障碍在CNS缺陷发病机制中的作用,以恢复选定CNS细胞类型或脑区域中的PEX 2功能。或者,我们将使用正常或过氧化物酶体缺陷的神经元祖细胞体内移植到正常或突变的发育中的大脑皮层或小脑。具体目标#2:肝脏因素是否导致过氧化物酶体缺陷小鼠的CNS缺陷?我们将评估当在PEX 2-/-小鼠体内纠正胆汁酸缺乏时,CNS发育如何改变。我们将确定胆汁酸产物是否在PEX 2/小鼠的大脑中积累。我们将通过确定添加外源性胆汁酸中间体或肝细胞条件培养基对对照、PEX 2-/、缩醛磷脂或B-氧化缺陷小鼠的体外神经元缺陷的影响来检查来自PEX 2突变体肝脏的毒性物质是否引起CNS功能障碍。具体目标#3:过氧化物酶体在小脑浦肯野细胞和/或颗粒神经元发育中的作用是什么?小脑浦肯野细胞和/或颗粒神经元中PEX 2基因的条件性缺失将决定在没有全身器官过氧化物酶体缺乏的情况下过氧化物酶体对这些神经元发育的作用。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHYLLIS L FAUST其他文献

PHYLLIS L FAUST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHYLLIS L FAUST', 18)}}的其他基金

Deep Dive: Mapping the Neuropathology of Essential Tremor and Exploring the Molecular Underpinnings of Neurodegeneration
深入探讨:绘制特发性震颤的神经病理学并探索神经退行性变的分子基础
  • 批准号:
    10210793
  • 财政年份:
    2021
  • 资助金额:
    $ 47.89万
  • 项目类别:
Targeting Cerebellar Endoplasmic Reticulum Calcium Handling in Essential Tremor
特发性震颤中靶向小脑内质网钙处理
  • 批准号:
    10346058
  • 财政年份:
    2021
  • 资助金额:
    $ 47.89万
  • 项目类别:
Deep Dive: Mapping the Neuropathology of Essential Tremor and Exploring the Molecular Underpinnings of Neurodegeneration
深入探讨:绘制特发性震颤的神经病理学并探索神经退行性变的分子基础
  • 批准号:
    10553702
  • 财政年份:
    2021
  • 资助金额:
    $ 47.89万
  • 项目类别:
Targeting Cerebellar Endoplasmic Reticulum Calcium Handling in Essential Tremor
特发性震颤中靶向小脑内质网钙处理
  • 批准号:
    10541251
  • 财政年份:
    2021
  • 资助金额:
    $ 47.89万
  • 项目类别:
Deep Dive: Mapping the Neuropathology of Essential Tremor and Exploring the Molecular Underpinnings of Neurodegeneration
深入探讨:绘制特发性震颤的神经病理学并探索神经退行性变的分子基础
  • 批准号:
    10378691
  • 财政年份:
    2021
  • 资助金额:
    $ 47.89万
  • 项目类别:
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF
病理组学 - 更广泛背景下的特发性震颤
  • 批准号:
    10307348
  • 财政年份:
    2020
  • 资助金额:
    $ 47.89万
  • 项目类别:
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION
病理组学 - 神经退行性更广泛背景下的特发性震颤
  • 批准号:
    8995706
  • 财政年份:
    2015
  • 资助金额:
    $ 47.89万
  • 项目类别:
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION
病理组学 - 神经退行性更广泛背景下的特发性震颤
  • 批准号:
    9213399
  • 财政年份:
    2015
  • 资助金额:
    $ 47.89万
  • 项目类别:
Essential Tremor: Gene expression profiling in cerebellar Purkinje cells
特发性震颤:小脑浦肯野细胞的基因表达谱
  • 批准号:
    8226636
  • 财政年份:
    2011
  • 资助金额:
    $ 47.89万
  • 项目类别:
Essential Tremor: Gene expression profiling in cerebellar Purkinje cells
特发性震颤:小脑浦肯野细胞的基因表达谱
  • 批准号:
    8320096
  • 财政年份:
    2011
  • 资助金额:
    $ 47.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了